Z-0602-2026 Class II Ongoing

Recalled by BioFire Diagnostics, LLC — Salt Lake City, UT

FDA device recall Z-0602-2026 was initiated by BioFire Diagnostics, LLC on Oct 22, 2025 and is designated Class II. Reason for recall: Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures. The recall status is ongoing. Affected quantity: 97 Kits (2,910 pouches).

Recall details

Product Type
Devices
Report Date
Dec 3, 2025
Initiation Date
Oct 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
97 Kits (2,910 pouches)

Product description

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

Reason for recall

Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

Distribution pattern

US:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: None

Code information

UDI: 00815381020529 /Lot # 2649724 Expanded Lot#: 1471725

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0602-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0602-2026. Report a data issue: hello@regdatalab.com.